These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 36976465)
21. The Complement Cascade as a Mediator of Human Malignant Hematopoietic Cell Trafficking. Lenkiewicz A; Bujko K; Brzezniakiewicz-Janus K; Xu B; Ratajczak MZ Front Immunol; 2019; 10():1292. PubMed ID: 31231394 [TBL] [Abstract][Full Text] [Related]
22. Defect in Migration of HSPCs in Nox-2 Deficient Mice Explained by Impaired Activation of Nlrp3 Inflammasome and Impaired Formation of Membrane Lipid Rafts. Bujko K; Adamiak M; Konopko A; Chumak V; Ratajczak J; Brzezniakiewicz-Janus K; Kucia M; Ratajczak MZ Stem Cell Rev Rep; 2024 Aug; ():. PubMed ID: 39134888 [TBL] [Abstract][Full Text] [Related]
23. Intracellular complement (complosome) is expressed in hematopoietic stem/progenitor cells (HSPCs) and regulates cell trafficking, metabolism and proliferation in an intracrine Nlrp3 inflammasome-dependent manner. Ratajczak MZ; Adamiak M; Abdelbaset-Ismail A; Bujko K; Thapa A; Chumak V; Franczak S; Brzezniakiewicz-Janus K; Ratajczak J; Kucia M Leukemia; 2023 Jun; 37(6):1401-1405. PubMed ID: 37055506 [No Abstract] [Full Text] [Related]
24. Novel Evidence That Alternative Pathway of Complement Cascade Activation is Required for Optimal Homing and Engraftment of Hematopoietic Stem/progenitor Cells. Adamiak M; Ciechanowicz A; Chumak V; Bujko K; Ratajczak J; Brzezniakiewicz-Janus K; Kucia M; Ratajczak MZ Stem Cell Rev Rep; 2022 Apr; 18(4):1355-1365. PubMed ID: 35013937 [TBL] [Abstract][Full Text] [Related]
25. Novel Evidence that Purinergic Signaling - Nlrp3 Inflammasome Axis Regulates Circadian Rhythm of Hematopoietic Stem/Progenitor Cells Circulation in Peripheral Blood. Adamiak M; Ciechanowicz A; Skoda M; Cymer M; Tracz M; Xu B; Ratajczak MZ Stem Cell Rev Rep; 2020 Apr; 16(2):335-343. PubMed ID: 31939051 [TBL] [Abstract][Full Text] [Related]
26. A novel "complement-metabolism-inflammasome axis" as a key regulator of immune cell effector function. Arbore G; Kemper C Eur J Immunol; 2016 Jul; 46(7):1563-73. PubMed ID: 27184294 [TBL] [Abstract][Full Text] [Related]
27. A Circadian Rhythm in both Complement Cascade (ComC) Activation and Sphingosine-1-Phosphate (S1P) Levels in Human Peripheral Blood Supports a Role for the ComC-S1P Axis in Circadian Changes in the Number of Stem Cells Circulating in Peripheral Blood. Budkowska M; Ostrycharz E; Wojtowicz A; Marcinowska Z; Woźniak J; Ratajczak MZ; Dołęgowska B Stem Cell Rev Rep; 2018 Oct; 14(5):677-685. PubMed ID: 29911288 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases. Seok JK; Kang HC; Cho YY; Lee HS; Lee JY Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121 [TBL] [Abstract][Full Text] [Related]
29. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Basiorka AA; McGraw KL; Eksioglu EA; Chen X; Johnson J; Zhang L; Zhang Q; Irvine BA; Cluzeau T; Sallman DA; Padron E; Komrokji R; Sokol L; Coll RC; Robertson AA; Cooper MA; Cleveland JL; O'Neill LA; Wei S; List AF Blood; 2016 Dec; 128(25):2960-2975. PubMed ID: 27737891 [TBL] [Abstract][Full Text] [Related]
30. Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1. Abdelbaset-Ismail A; Borkowska-Rzeszotek S; Kubis E; Bujko K; Brzeźniakiewicz-Janus K; Bolkun L; Kloczko J; Moniuszko M; Basak GW; Wiktor-Jedrzejczak W; Ratajczak MZ Leukemia; 2017 Feb; 31(2):446-458. PubMed ID: 27451975 [TBL] [Abstract][Full Text] [Related]
31. The role of innate immunity in trafficking of hematopoietic stem cells-an emerging link between activation of complement cascade and chemotactic gradients of bioactive sphingolipids. Ratajczak MZ; Kim C; Wu W; Shin DM; Bryndza E; Kucia M; Ratajczak J Adv Exp Med Biol; 2012; 946():37-54. PubMed ID: 21948361 [TBL] [Abstract][Full Text] [Related]
32. Acinetobacter baumannii outer membrane protein 34 elicits NLRP3 inflammasome activation via mitochondria-derived reactive oxygen species in RAW264.7 macrophages. An Z; Su J Microbes Infect; 2019; 21(3-4):143-153. PubMed ID: 30439507 [TBL] [Abstract][Full Text] [Related]
33. Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). Borkowska S; Suszynska M; Mierzejewska K; Ismail A; Budkowska M; Salata D; Dolegowska B; Kucia M; Ratajczak J; Ratajczak MZ Leukemia; 2014 Nov; 28(11):2148-54. PubMed ID: 24667943 [TBL] [Abstract][Full Text] [Related]
35. Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications. Ratajczak MZ; Adamiak M; Ratajczak J; Kucia M Stem Cell Rev Rep; 2021 Jun; 17(3):821-828. PubMed ID: 33196976 [TBL] [Abstract][Full Text] [Related]
36. Cellular Models and Assays to Study NLRP3 Inflammasome Biology. Zito G; Buscetta M; Cimino M; Dino P; Bucchieri F; Cipollina C Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560261 [TBL] [Abstract][Full Text] [Related]
37. NLRP3 Inflammasome-A Key Player in Antiviral Responses. Zhao C; Zhao W Front Immunol; 2020; 11():211. PubMed ID: 32133002 [TBL] [Abstract][Full Text] [Related]
38. Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing. Wysoczynski M; Reca R; Lee H; Wu W; Ratajczak J; Ratajczak MZ Leukemia; 2009 Aug; 23(8):1455-61. PubMed ID: 19357704 [TBL] [Abstract][Full Text] [Related]
39. Novel evidence that an alternative complement cascade pathway is involved in optimal mobilization of hematopoietic stem/progenitor cells in Nlrp3 inflammasome-dependent manner. Adamiak M; Lenkiewicz AM; Cymer M; Kucia M; Ratajczak J; Ratajczak MZ Leukemia; 2019 Dec; 33(12):2967-2970. PubMed ID: 31350529 [No Abstract] [Full Text] [Related]
40. Activation and regulation mechanisms of NOD-like receptors based on structural biology. Ohto U Front Immunol; 2022; 13():953530. PubMed ID: 36189327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]